ARTICLE | Clinical News
Calsed amrubicin regulatory update
September 10, 2012 7:00 AM UTC
Dainippon submitted a regulatory application to China's State Food and Drug Administration (SFDA) for amrubicin as first-line treatment for small cell lung cancer (SCLC). Celgene has North American an...